205 related articles for article (PubMed ID: 34470501)
1. Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.
Mahfoud F; Sievert H; Bertog S; Lauder L; Ewen S; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Weber MA; Kandzari DE; Parise H; Fischell TA; Pathak A; Persu A
Circ Cardiovasc Interv; 2021 Sep; 14(9):e010075. PubMed ID: 34470501
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
Fischell TA; Ebner A; Gallo S; Ikeno F; Minarsch L; Vega F; Haratani N; Ghazarossian VE
JACC Cardiovasc Interv; 2016 Mar; 9(6):589-98. PubMed ID: 27013159
[TBL] [Abstract][Full Text] [Related]
3. Renal sympathetic denervation in a previously stented renal artery.
Berra E; Rabbia F; Rossato D; Covella M; Totaro S; Chiara F; Di Monaco S; Veglio F
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):238-9. PubMed ID: 24387740
[No Abstract] [Full Text] [Related]
4. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
5. Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter.
Bertog S; Sharma A; Mahfoud F; Pathak A; Schmieder RE; Sievert K; Papademetriou V; Weber MA; Haratani N; Lobo MD; Saxena M; Kandzari DE; Fischell TA; Sievert H
Cardiovasc Revasc Med; 2021 Mar; 24():77-86. PubMed ID: 32958438
[TBL] [Abstract][Full Text] [Related]
6. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
de Leon-Martinez EP; Garza JA; Azpiri-Lopez JR; Dillon KN; Salazar LO; Canepa-Campos F; Rousselle SD; Tellez A
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):445-8. PubMed ID: 26014838
[TBL] [Abstract][Full Text] [Related]
7. [Second chance for renal artery denervation].
Chepurnoĭ AG; Shugushev ZK; Maksimkin DA
Angiol Sosud Khir; 2021; 27(2):32-40. PubMed ID: 34166342
[TBL] [Abstract][Full Text] [Related]
8. Renal denervation for resistant hypertension: closing in on potential confounders.
Schlaich MP; Schultz C; Shetty S
J Hypertens; 2016 Aug; 34(8):1505-6. PubMed ID: 27356001
[No Abstract] [Full Text] [Related]
9. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
[TBL] [Abstract][Full Text] [Related]
10. Late renal artery stenosis after percutaneous renal denervation.
Lambert T; Blessberger H; Grund M; Steinwender C
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based renal denervation in hypertension: heading for new shores.
Mahfoud F; Böhm M; Edelman ER
J Hypertens; 2018 Jan; 36(1):41-42. PubMed ID: 29210859
[No Abstract] [Full Text] [Related]
12. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
13. Renal denervation for resistant hypertension: acute results and long-term follow-up.
Korovesis S; Giazitzoglou E; Pantos I; Tzanalaridou E; Kokladi M; Venetsanakos I; Paxinos G; Katritsis DG
Hellenic J Cardiol; 2014; 55(3):211-6. PubMed ID: 24862613
[TBL] [Abstract][Full Text] [Related]
14. Renal denervation vascular effects: An "insider's" view.
Dimitriadis K; Tsioufis C
Hellenic J Cardiol; 2020; 61(3):197-198. PubMed ID: 32916295
[TBL] [Abstract][Full Text] [Related]
15. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
16. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
17. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
Mahfoud F; Renkin J; Sievert H; Bertog S; Ewen S; Böhm M; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Parise H; Haratani N; Pathak A; Persu A
JACC Cardiovasc Interv; 2020 Feb; 13(4):471-484. PubMed ID: 32081241
[TBL] [Abstract][Full Text] [Related]
18. First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter.
Honton B; Pathak A; Sauguet A; Fajadet J
EuroIntervention; 2014; 9(12):1385-8. PubMed ID: 24161437
[TBL] [Abstract][Full Text] [Related]
19. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
Laffin LJ; Bakris GL
Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
[TBL] [Abstract][Full Text] [Related]
20. Now That Renal Denervation Works, How Do We Proceed?
Papademetriou V; Stavropoulos K; Doumas M; Tsioufis K
Circ Res; 2019 Mar; 124(5):693-695. PubMed ID: 30817252
[No Abstract] [Full Text] [Related]
[Next] [New Search]
